Antibiotic & Anti-Inflammatory Eye Ointment Franchise in Ahmedabad

Polyflip Max Eye Ointment Supplier in Mumbai

Steroid-Antibiotic Eye Ointment Distributor in Delhi

Ophthalmic PCD Pharma Franchise in Bangalore

Polyflip Max Eye Ointment Stockist in Hyderabad
Anti-Inflammatory & Antibiotic Eye Ointment Manufacturer & Exporter in Chandigarh

Home/Products /neomycin-5000-units-polymyxin-b-sulfate-bacitracin-eye-ointment

Polyflip Max Eye Ointment

Composition : Neomycin (5000 units) + Polymyxin B Sulfate (400 units) + Bacitracin Zinc (3400 units) + Hydrocortisone (10 mg) Eye Ointment

Dosage Form : Eye Ointment

Packaging Type : Tube

Packaging : 5gm

Price : ₹0/-

Polyflip Max Eye Ointment contains Neomycin 5000 IU + Polymyxin B 400 IU + Bacitracin Zinc 3400 IU + Hydrocortisone 10 mg, a combination steroid-antibiotic ophthalmic ointment used for bacterial eye infections with associated inflammation.

It works by eliminating bacterial pathogens while reducing redness, swelling, and irritation, providing fast relief and improved ocular comfort.

Clinically, Polyflip Max Eye Ointment is suitable for short-term inflammatory bacterial eye conditions, ensuring prolonged contact and effective treatment.

From a business perspective, Polyflip Max Eye Ointment strengthens the steroid-antibiotic therapy segment, offering high prescription demand, repeat sales, and strong PCD pharma franchise potential at a best price for franchise partners.

Read More

About the Product

Polyflip Max Eye Ointment contains Neomycin 5000 IU + Polymyxin B 400 IU + Bacitracin Zinc 3400 IU + Hydrocortisone 10 mg, a combination steroid-antibiotic ophthalmic ointment used for bacterial eye infections with associated inflammation.

It works by eliminating bacterial pathogens while reducing redness, swelling, and irritation, providing fast relief and improved ocular comfort.

Clinically, Polyflip Max Eye Ointment is suitable for short-term inflammatory bacterial eye conditions, ensuring prolonged contact and effective treatment.

From a business perspective, Polyflip Max Eye Ointment strengthens the steroid-antibiotic therapy segment, offering high prescription demand, repeat sales, and strong PCD pharma franchise potential at a best price for franchise partners.

Common side effects may include temporary blurred vision, mild burning or stinging, eye irritation, or redness. Rarely, hypersensitivity reactions, delayed wound healing, or increased intraocular pressure may occur with prolonged use.

Polyflip Max Eye Ointment is indicated for the treatment of bacterial eye infections with associated inflammation, including conjunctivitis, keratitis, blepharitis, and other steroid-responsive ocular inflammatory conditions caused or complicated by susceptible bacteria.

Use Polyflip Max Eye Ointment strictly as prescribed by an ophthalmologist. Avoid touching the tube tip to the eye or any surface to prevent contamination. Do not use in viral or fungal eye infections unless prescribed with appropriate therapy. Complete the course as directed and discontinue if severe irritation or allergic reaction occurs.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the tube tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation